In-Depth Examination Of 4 Analyst Recommendations For ANI Pharmaceuticals
In-Depth Examination Of 4 Analyst Recommendations For ANI Pharmaceuticals
ani pharmaceuticals的4位分析師推薦的深入分析
ANI Pharmaceuticals (NASDAQ:ANIP) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 0 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $85.5, a high estimate of $94.00, and a low estimate of $60.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 3.66%.
Interpreting Analyst Ratings: A Closer Look
The perception of ANI Pharmaceuticals by financial experts...
登入免費觀看全文
登入/註冊